Retinal Health
Pipeline
About our Retinal Health efforts
The ambition to prevent vision loss in people at risk, and preserve or restore vision in those with retinal diseases, is at the core of our R&D activities. Our extensive knowledge and insights from other therapeutic areas enable us to tackle the multifactorial pathophysiology of retinal diseases. Areas of focus include wet age-related macular degeneration, diabetic retinopathy and geographic atrophy.
Read more about BI 764524: Sema3A antibody
Retinal Health
Diabetic retinopathy
Sema3A antibody
BI 764524